Nest.Bio Venture is a US-based venture capital firm specializing in the life sciences sector, with a focus on biotechnology, pharmaceuticals, and medical research. The firm typically invests in early-stage companies, participating in Seed and Series A rounds, with occasional involvement in Series B rounds. Their investment size varies, supporting companies through significant growth phases.
Notable portfolio companies include Astrocyte Pharmaceuticals, PAQ Therapeutics, Platelet BioGenesis, RootPath Genomics, and Senti Biosciences. Nest.Bio Venture is known for its deep sector expertise and strategic support, offering more than just capital by providing valuable industry connections and guidance to foster innovation and growth within their portfolio.
Nest.Bio Venture - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Follow-on Investments3
Current Portfolio Count5
Top Investment Stages
Series A5 (62.5%)
Seed2 (25.0%)
Series B1 (12.5%)
Stage Mix
Series A 63%Seed 25%Series B 13%
Concentration shown as share of disclosed investments by stage.
Nest.Bio Venture - Classification
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
